SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

News in brief

Olympus Biotech launches drug and biologic CMO

04-Oct-2012

The CMO sector welcomed its newest member this week with Olympus Biotech launching a drug contract manufacturing business.

The new service – at Olympus’ facility in Lebanon, New Hampshire – will cater for pharmas and biopharmas with capabilities to make batches of drugs and biologics for clinical assessment and commercial supply.

Peter Gariepy, VP of operations, said: “The increasing number of monoclonal antibodies and recombinant proteins in the market and in development has fueled a need for experienced, sophisticated manufacturing partners that can support pre-clinical through commercial production.”

The move is something of a departure for Olympus Biotech - which is part of global manufacturing group Olympus – which previously focused the production of regenerative bone graft implants and materials.

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

Key Industry Events

 

Access all events listing

Our events, Events from partners...